1. Home
  2. English
  3. Healthcare

Healthcare

Covid-19: Covovax Approved for 12-17 Age Group

NEW DELHI, April 29: The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India’s (SII) Covid-19 vaccine Covovax for the 12-17 age group. “The government panel decided to include Covovax in India’s immunisation drive against Covid-19,” official sources said. This makes Covovax another option for vaccines for children between the ages […]
Join our WhatsApp Channel

And stay informed with the latest news and updates.

Join Now
revoi whats app qr code